[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Injection Influenza Vaccine Market, Global Outlook and Forecast 2022-2028

April 2022 | 74 pages | ID: I91EDC949181EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

This report contains market size and forecasts of Injection Influenza Vaccine in global, including the following market information:

Global Injection Influenza Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Injection Influenza Vaccine Market Sales, 2017-2022, 2023-2028, (Units)

Global top five Injection Influenza Vaccine companies in 2021 (%)

The global Injection Influenza Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Trivalent Influenza Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Injection Influenza Vaccine include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and Jiangsu GDK and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Injection Influenza Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Injection Influenza Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Injection Influenza Vaccine Market Segment Percentages, by Type, 2021 (%)
  • Trivalent Influenza Vaccine
  • Quadrivalent Influenza Vaccine
Global Injection Influenza Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Injection Influenza Vaccine Market Segment Percentages, by Application, 2021 (%)
  • 6 Months to 3 Years
  • > 3 Years
Global Injection Influenza Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Injection Influenza Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Injection Influenza Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Injection Influenza Vaccine revenues share in global market, 2021 (%)

Key companies Injection Influenza Vaccine sales in global market, 2017-2022 (Estimated), (Units)

Key companies Injection Influenza Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Sanofi
  • CSL
  • GSK
  • Viatris
  • AstraZeneca
  • Hualan Bio
  • Changchun Institute of Biological
  • Sinovac
  • Jiangsu GDK
  • KM Biologics
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Injection Influenza Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Injection Influenza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INJECTION INFLUENZA VACCINE OVERALL MARKET SIZE

2.1 Global Injection Influenza Vaccine Market Size: 2021 VS 2028
2.2 Global Injection Influenza Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Injection Influenza Vaccine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Injection Influenza Vaccine Players in Global Market
3.2 Top Global Injection Influenza Vaccine Companies Ranked by Revenue
3.3 Global Injection Influenza Vaccine Revenue by Companies
3.4 Global Injection Influenza Vaccine Sales by Companies
3.5 Global Injection Influenza Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Injection Influenza Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Injection Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Injection Influenza Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 Injection Influenza Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Injection Influenza Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Injection Influenza Vaccine Market Size Markets, 2021 & 2028
  4.1.2 Trivalent Influenza Vaccine
  4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - Global Injection Influenza Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Injection Influenza Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Injection Influenza Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Injection Influenza Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Injection Influenza Vaccine Sales & Forecasts
  4.3.1 By Type - Global Injection Influenza Vaccine Sales, 2017-2022
  4.3.2 By Type - Global Injection Influenza Vaccine Sales, 2023-2028
  4.3.3 By Type - Global Injection Influenza Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Injection Influenza Vaccine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Injection Influenza Vaccine Market Size, 2021 & 2028
  5.1.2 6 Months to 3 Years
  5.1.3 > 3 Years
5.2 By Application - Global Injection Influenza Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Injection Influenza Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Injection Influenza Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Injection Influenza Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Injection Influenza Vaccine Sales & Forecasts
  5.3.1 By Application - Global Injection Influenza Vaccine Sales, 2017-2022
  5.3.2 By Application - Global Injection Influenza Vaccine Sales, 2023-2028
  5.3.3 By Application - Global Injection Influenza Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Injection Influenza Vaccine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Injection Influenza Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Injection Influenza Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Injection Influenza Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Injection Influenza Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Injection Influenza Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Injection Influenza Vaccine Sales & Forecasts
  6.3.1 By Region - Global Injection Influenza Vaccine Sales, 2017-2022
  6.3.2 By Region - Global Injection Influenza Vaccine Sales, 2023-2028
  6.3.3 By Region - Global Injection Influenza Vaccine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Injection Influenza Vaccine Revenue, 2017-2028
  6.4.2 By Country - North America Injection Influenza Vaccine Sales, 2017-2028
  6.4.3 US Injection Influenza Vaccine Market Size, 2017-2028
  6.4.4 Canada Injection Influenza Vaccine Market Size, 2017-2028
  6.4.5 Mexico Injection Influenza Vaccine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Injection Influenza Vaccine Revenue, 2017-2028
  6.5.2 By Country - Europe Injection Influenza Vaccine Sales, 2017-2028
  6.5.3 Germany Injection Influenza Vaccine Market Size, 2017-2028
  6.5.4 France Injection Influenza Vaccine Market Size, 2017-2028
  6.5.5 U.K. Injection Influenza Vaccine Market Size, 2017-2028
  6.5.6 Italy Injection Influenza Vaccine Market Size, 2017-2028
  6.5.7 Russia Injection Influenza Vaccine Market Size, 2017-2028
  6.5.8 Nordic Countries Injection Influenza Vaccine Market Size, 2017-2028
  6.5.9 Benelux Injection Influenza Vaccine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Injection Influenza Vaccine Revenue, 2017-2028
  6.6.2 By Region - Asia Injection Influenza Vaccine Sales, 2017-2028
  6.6.3 China Injection Influenza Vaccine Market Size, 2017-2028
  6.6.4 Japan Injection Influenza Vaccine Market Size, 2017-2028
  6.6.5 South Korea Injection Influenza Vaccine Market Size, 2017-2028
  6.6.6 Southeast Asia Injection Influenza Vaccine Market Size, 2017-2028
  6.6.7 India Injection Influenza Vaccine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Injection Influenza Vaccine Revenue, 2017-2028
  6.7.2 By Country - South America Injection Influenza Vaccine Sales, 2017-2028
  6.7.3 Brazil Injection Influenza Vaccine Market Size, 2017-2028
  6.7.4 Argentina Injection Influenza Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Injection Influenza Vaccine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Injection Influenza Vaccine Sales, 2017-2028
  6.8.3 Turkey Injection Influenza Vaccine Market Size, 2017-2028
  6.8.4 Israel Injection Influenza Vaccine Market Size, 2017-2028
  6.8.5 Saudi Arabia Injection Influenza Vaccine Market Size, 2017-2028
  6.8.6 UAE Injection Influenza Vaccine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Injection Influenza Vaccine Major Product Offerings
  7.1.4 Sanofi Injection Influenza Vaccine Sales and Revenue in Global (2017-2022)
  7.1.5 Sanofi Key News
7.2 CSL
  7.2.1 CSL Corporate Summary
  7.2.2 CSL Business Overview
  7.2.3 CSL Injection Influenza Vaccine Major Product Offerings
  7.2.4 CSL Injection Influenza Vaccine Sales and Revenue in Global (2017-2022)
  7.2.5 CSL Key News
7.3 GSK
  7.3.1 GSK Corporate Summary
  7.3.2 GSK Business Overview
  7.3.3 GSK Injection Influenza Vaccine Major Product Offerings
  7.3.4 GSK Injection Influenza Vaccine Sales and Revenue in Global (2017-2022)
  7.3.5 GSK Key News
7.4 Viatris
  7.4.1 Viatris Corporate Summary
  7.4.2 Viatris Business Overview
  7.4.3 Viatris Injection Influenza Vaccine Major Product Offerings
  7.4.4 Viatris Injection Influenza Vaccine Sales and Revenue in Global (2017-2022)
  7.4.5 Viatris Key News
7.5 AstraZeneca
  7.5.1 AstraZeneca Corporate Summary
  7.5.2 AstraZeneca Business Overview
  7.5.3 AstraZeneca Injection Influenza Vaccine Major Product Offerings
  7.5.4 AstraZeneca Injection Influenza Vaccine Sales and Revenue in Global (2017-2022)
  7.5.5 AstraZeneca Key News
7.6 Hualan Bio
  7.6.1 Hualan Bio Corporate Summary
  7.6.2 Hualan Bio Business Overview
  7.6.3 Hualan Bio Injection Influenza Vaccine Major Product Offerings
  7.6.4 Hualan Bio Injection Influenza Vaccine Sales and Revenue in Global (2017-2022)
  7.6.5 Hualan Bio Key News
7.7 Changchun Institute of Biological
  7.7.1 Changchun Institute of Biological Corporate Summary
  7.7.2 Changchun Institute of Biological Business Overview
  7.7.3 Changchun Institute of Biological Injection Influenza Vaccine Major Product Offerings
  7.7.4 Changchun Institute of Biological Injection Influenza Vaccine Sales and Revenue in Global (2017-2022)
  7.7.5 Changchun Institute of Biological Key News
7.8 Sinovac
  7.8.1 Sinovac Corporate Summary
  7.8.2 Sinovac Business Overview
  7.8.3 Sinovac Injection Influenza Vaccine Major Product Offerings
  7.8.4 Sinovac Injection Influenza Vaccine Sales and Revenue in Global (2017-2022)
  7.8.5 Sinovac Key News
7.9 Jiangsu GDK
  7.9.1 Jiangsu GDK Corporate Summary
  7.9.2 Jiangsu GDK Business Overview
  7.9.3 Jiangsu GDK Injection Influenza Vaccine Major Product Offerings
  7.9.4 Jiangsu GDK Injection Influenza Vaccine Sales and Revenue in Global (2017-2022)
  7.9.5 Jiangsu GDK Key News
7.10 KM Biologics
  7.10.1 KM Biologics Corporate Summary
  7.10.2 KM Biologics Business Overview
  7.10.3 KM Biologics Injection Influenza Vaccine Major Product Offerings
  7.10.4 KM Biologics Injection Influenza Vaccine Sales and Revenue in Global (2017-2022)
  7.10.5 KM Biologics Key News

8 GLOBAL INJECTION INFLUENZA VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Injection Influenza Vaccine Production Capacity, 2017-2028
8.2 Injection Influenza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Injection Influenza Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 INJECTION INFLUENZA VACCINE SUPPLY CHAIN ANALYSIS

10.1 Injection Influenza Vaccine Industry Value Chain
10.2 Injection Influenza Vaccine Upstream Market
10.3 Injection Influenza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Injection Influenza Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Injection Influenza Vaccine in Global Market
Table 2. Top Injection Influenza Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Injection Influenza Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Injection Influenza Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Injection Influenza Vaccine Sales by Companies, (Units), 2017-2022
Table 6. Global Injection Influenza Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Injection Influenza Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Injection Influenza Vaccine Product Type
Table 9. List of Global Tier 1 Injection Influenza Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Injection Influenza Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Injection Influenza Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Injection Influenza Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Injection Influenza Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Injection Influenza Vaccine Sales (Units), 2017-2022
Table 15. By Type - Global Injection Influenza Vaccine Sales (Units), 2023-2028
Table 16. By Application – Global Injection Influenza Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Injection Influenza Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Injection Influenza Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Injection Influenza Vaccine Sales (Units), 2017-2022
Table 20. By Application - Global Injection Influenza Vaccine Sales (Units), 2023-2028
Table 21. By Region – Global Injection Influenza Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Injection Influenza Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Injection Influenza Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Injection Influenza Vaccine Sales (Units), 2017-2022
Table 25. By Region - Global Injection Influenza Vaccine Sales (Units), 2023-2028
Table 26. By Country - North America Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Injection Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Injection Influenza Vaccine Sales, (Units), 2017-2022
Table 29. By Country - North America Injection Influenza Vaccine Sales, (Units), 2023-2028
Table 30. By Country - Europe Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Injection Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Injection Influenza Vaccine Sales, (Units), 2017-2022
Table 33. By Country - Europe Injection Influenza Vaccine Sales, (Units), 2023-2028
Table 34. By Region - Asia Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Injection Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Injection Influenza Vaccine Sales, (Units), 2017-2022
Table 37. By Region - Asia Injection Influenza Vaccine Sales, (Units), 2023-2028
Table 38. By Country - South America Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Injection Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Injection Influenza Vaccine Sales, (Units), 2017-2022
Table 41. By Country - South America Injection Influenza Vaccine Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Injection Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Injection Influenza Vaccine Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Injection Influenza Vaccine Sales, (Units), 2023-2028
Table 46. Sanofi Corporate Summary
Table 47. Sanofi Injection Influenza Vaccine Product Offerings
Table 48. Sanofi Injection Influenza Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. CSL Corporate Summary
Table 50. CSL Injection Influenza Vaccine Product Offerings
Table 51. CSL Injection Influenza Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. GSK Corporate Summary
Table 53. GSK Injection Influenza Vaccine Product Offerings
Table 54. GSK Injection Influenza Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Viatris Corporate Summary
Table 56. Viatris Injection Influenza Vaccine Product Offerings
Table 57. Viatris Injection Influenza Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Injection Influenza Vaccine Product Offerings
Table 60. AstraZeneca Injection Influenza Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Hualan Bio Corporate Summary
Table 62. Hualan Bio Injection Influenza Vaccine Product Offerings
Table 63. Hualan Bio Injection Influenza Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Changchun Institute of Biological Corporate Summary
Table 65. Changchun Institute of Biological Injection Influenza Vaccine Product Offerings
Table 66. Changchun Institute of Biological Injection Influenza Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Sinovac Corporate Summary
Table 68. Sinovac Injection Influenza Vaccine Product Offerings
Table 69. Sinovac Injection Influenza Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Jiangsu GDK Corporate Summary
Table 71. Jiangsu GDK Injection Influenza Vaccine Product Offerings
Table 72. Jiangsu GDK Injection Influenza Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. KM Biologics Corporate Summary
Table 74. KM Biologics Injection Influenza Vaccine Product Offerings
Table 75. KM Biologics Injection Influenza Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Injection Influenza Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 77. Global Injection Influenza Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Injection Influenza Vaccine Production by Region, 2017-2022 (Units)
Table 79. Global Injection Influenza Vaccine Production by Region, 2023-2028 (Units)
Table 80. Injection Influenza Vaccine Market Opportunities & Trends in Global Market
Table 81. Injection Influenza Vaccine Market Drivers in Global Market
Table 82. Injection Influenza Vaccine Market Restraints in Global Market
Table 83. Injection Influenza Vaccine Raw Materials
Table 84. Injection Influenza Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Injection Influenza Vaccine Downstream
Table 86. Injection Influenza Vaccine Downstream Clients in Global Market
Table 87. Injection Influenza Vaccine Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Injection Influenza Vaccine Segment by Type
Figure 2. Injection Influenza Vaccine Segment by Application
Figure 3. Global Injection Influenza Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Injection Influenza Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Injection Influenza Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Injection Influenza Vaccine Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Injection Influenza Vaccine Revenue in 2021
Figure 9. By Type - Global Injection Influenza Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Injection Influenza Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Injection Influenza Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Injection Influenza Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Injection Influenza Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Injection Influenza Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Injection Influenza Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Injection Influenza Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Injection Influenza Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Injection Influenza Vaccine Sales Market Share, 2017-2028
Figure 19. US Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Injection Influenza Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Injection Influenza Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Injection Influenza Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Injection Influenza Vaccine Sales Market Share, 2017-2028
Figure 33. China Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Injection Influenza Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Injection Influenza Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Injection Influenza Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Injection Influenza Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Injection Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Injection Influenza Vaccine Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Injection Influenza Vaccine by Region, 2021 VS 2028
Figure 50. Injection Influenza Vaccine Industry Value Chain
Figure 51. Marketing Channels


More Publications